%0 Journal Article %1 Willenborg2002 %A Willenborg, Michael J %A Shilt, Jeffrey S %A Smith, Beth Paterson %A Estrada, Roquel L %A Castle, Jason A %A Koman, L. Andrew %D 2002 %J J Pediatr Orthop %K Botulinum Toxin Type A; Cerebral Palsy; Electromyography; Female; Hip; Humans; Injections, Intramuscular; Male; Psoas Muscles %N 2 %P 165--168 %T Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum a toxin injection in cerebral palsy. %V 22 %X Symptomatic hip flexion deformity secondary to iliopsoas spasticity may interfere with gait, impair sitting balance, or contribute to hip subluxation or dislocation. A nonsurgical, minimally invasive technique to ameliorate iliopsoas spasticity is presented. The technique uses intramuscular injections of botulinum A toxin to provide selective neuromuscular blockade of the iliacus or psoas muscles or both. Because of the anatomic location of the target muscles, this technique uses ultrasound guidance for needle placement. Active electromyographic stimulation is used to verify the needle position adjacent to active myoneural interfaces. The authors' experience to date includes the treatment of 28 patients (53 hips). Use of this technique has resulted in improved hip range of motion. No intraoperative or postoperative adverse events or complications have been observed.

@article{Willenborg2002, abstract = {Symptomatic hip flexion deformity secondary to iliopsoas spasticity may interfere with gait, impair sitting balance, or contribute to hip subluxation or dislocation. A nonsurgical, minimally invasive technique to ameliorate iliopsoas spasticity is presented. The technique uses intramuscular injections of botulinum A toxin to provide selective neuromuscular blockade of the iliacus or psoas muscles or both. Because of the anatomic location of the target muscles, this technique uses ultrasound guidance for needle placement. Active electromyographic stimulation is used to verify the needle position adjacent to active myoneural interfaces. The authors' experience to date includes the treatment of 28 patients (53 hips). Use of this technique has resulted in improved hip range of motion. No intraoperative or postoperative adverse events or complications have been observed.}, added-at = {2014-07-19T21:55:00.000+0200}, author = {Willenborg, Michael J and Shilt, Jeffrey S and Smith, Beth Paterson and Estrada, Roquel L and Castle, Jason A and Koman, L. Andrew}, biburl = {https://www.bibsonomy.org/bibtex/2b5a40a2413034ba3a126162d36841855/ar0berts}, groups = {public}, interhash = {2e5623981cae14645b3b57b19f5ce9a9}, intrahash = {b5a40a2413034ba3a126162d36841855}, journal = {J Pediatr Orthop}, keywords = {Botulinum Toxin Type A; Cerebral Palsy; Electromyography; Female; Hip; Humans; Injections, Intramuscular; Male; Psoas Muscles}, number = 2, pages = {165--168}, pmid = {11856922}, timestamp = {2014-07-19T21:55:00.000+0200}, title = {Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum a toxin injection in cerebral palsy.}, username = {ar0berts}, volume = 22, year = 2002 }